| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2016 | Michele Trucksis | Chief Medical Officer and EVP | Sale+OE | 38,064 | $35.14 | $1,337,511.86 | - | |
| Jul 25, 2016 | John G. Aunins | Chief Technology Officer & EVP | Sale+OE | 9,390 | $34.18 | $320,950.20 | -4.3% | |
| Jul 6, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 88,211 | $29.45 | $2,597,473.97 | -32.4% | |
| Jul 1, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 56,789 | $29.81 | $1,692,704.72 | -23.6% | |
| Jun 30, 2016 | Eric D. Shaff69 | CFO and EVP | Sale+OE | 4,533 | $29.54 | $133,904.82 | - | |
| Jun 28, 2016 | Eric D. Shaff69 | CFO and EVP | Sale+OE | 5,001 | $28.28 | $141,444.95 | - | |
| Jun 27, 2016 | John G. Aunins | Chief Technology Officer & EVP | Sell | 9,390 | $27.23 | $255,689.70 | -22.3% | |
| Jun 2, 2016 | David N Cook | Chief Scientific Officer & EVP | Sell | 8,000 | $31.00 | $248,000.00 | -5.5% | |
| Jun 2, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 74,049 | $32.52 | $2,407,915.67 | -28.7% | |
| Jun 1, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 70,951 | $30.51 | $2,164,837.85 | -27.9% |